Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
| Image |  |
|---|---|
| Description | scientific article published on 18 August 2016 |
| Author/s |
author: Keiichi Fujiwara Ignace Vergote Christian Marth Bradley J. Monk Isabelle Ray-Coquard |
| Publication date | August 18, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |